KRMD Repro Med Systems Inc

Price (delayed)

$4.18

Market cap

$185.97M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.07

Enterprise value

$159.4M

Highlights
KRMD's debt has dropped by 89% year-on-year and by 15% since the previous quarter
The company's equity rose by 4.5% QoQ
The quick ratio has soared by 164% YoY but it has contracted by 18% from the previous quarter
The net income has dropped by 142% since the previous quarter
KRMD's EPS has dropped by 133% since the previous quarter

Key stats

What are the main financial stats of KRMD
Market
Shares outstanding
44.49M
Market cap
$185.97M
Enterprise value
$159.4M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
4.92
Price to sales (P/S)
7.89
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.85
Earnings
Revenue
$23.28M
EBIT
-$4M
EBITDA
-$3.56M
Free cash flow
-$4.38M
Per share
EPS
-$0.07
Free cash flow per share
-$0.1
Book value per share
$0.85
Revenue per share
$0.53
TBVPS
$0.94
Balance sheet
Total assets
$42.37M
Total liabilities
$4.59M
Debt
$203,441
Equity
$37.78M
Working capital
$34.55M
Liquidity
Debt to equity
0.01
Current ratio
8.63
Quick ratio
6.7
Net debt/EBITDA
7.47
Margins
EBITDA margin
-15.3%
Gross margin
61.8%
Net margin
-12.6%
Operating margin
-17.4%
Efficiency
Return on assets
-6.7%
Return on equity
-7.7%
Return on invested capital
-53.5%
Return on capital employed
-10.6%
Return on sales
-17.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

KRMD stock price

How has the Repro Med Systems stock price performed over time
Intraday
-3.02%
1 week
-7.93%
1 month
0%
1 year
-59.14%
YTD
-30.56%
QTD
18.75%

Financial performance

How have Repro Med Systems's revenue and profit performed over time
Revenue
$23.28M
Gross profit
$14.38M
Operating income
-$4.05M
Net income
-$2.94M
Gross margin
61.8%
Net margin
-12.6%
KRMD's net margin has dropped by 152% since the previous quarter
The net income has dropped by 142% since the previous quarter
The gross profit has declined by 8% year-on-year and by 3.7% since the previous quarter
The revenue has contracted by 5% YoY and by 3.7% from the previous quarter

Growth

What is Repro Med Systems's growth rate over time

Valuation

What is Repro Med Systems stock price valuation
P/E
N/A
P/B
4.92
P/S
7.89
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.85
KRMD's EPS has dropped by 133% since the previous quarter
KRMD's price to book (P/B) is 43% lower than its 5-year quarterly average of 8.7 and 31% lower than its last 4 quarters average of 7.1
The company's equity rose by 4.5% QoQ
The P/S is 26% below the last 4 quarters average of 10.7 but 25% above the 5-year quarterly average of 6.3
The revenue has contracted by 5% YoY and by 3.7% from the previous quarter

Efficiency

How efficient is Repro Med Systems business performance
Repro Med Systems's return on assets has shrunk by 185% YoY and by 109% QoQ
KRMD's return on invested capital has dropped by 185% since the previous quarter
Repro Med Systems's ROE has plunged by 177% YoY and by 103% from the previous quarter

Dividends

What is KRMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for KRMD.

Financial health

How did Repro Med Systems financials performed over time
The quick ratio has soared by 164% YoY but it has contracted by 18% from the previous quarter
The total assets has soared by 155% YoY and by 6% from the previous quarter
KRMD's debt is 99% smaller than its equity
The debt to equity has shrunk by 93% YoY
KRMD's debt has dropped by 89% year-on-year and by 15% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.